Mark Leventhal To Address Nixon Peabody LLP

Tuesday, March 11, 2008 General News J E 4
WASHINGTON, March 10 Leventhal Weight Loss Incorporated,the first in the nation executive weight loss coaching service for attorneysby an attorney,, today announced that its presidentand founder Mark Leventhal, Esq. will address the Washington, D.C. office ofNixon Peabody LLP this Wednesday, March 12, 2008.

Mark Leventhal, Esq., who lost over 50 pounds while practicinginternational trade law in a Washington, D.C. law firm and who has since runnine marathons, has previously been featured in the ABA Journal, TheWashington Post, Washington Lawyer, The Wall Street Journal, and WeightWatchers magazine. He has also appeared on the WUSA-TV (Channel 9) news in afeatured entitled, "Losing Weight in 2008."

"Lawyers have not been excluded from the obesity epidemic our nation isfacing. Obesity is an important issue that needs to be addressed in the legalcommunity. I personally know lawyers whose weight-related issues haveadversely impacted their ability to practice law," said Leventhal. "Having apersonal executive coach is a very effective way to lose weight. It providesthe accountability, support, and motivation that is lacking in other weightloss programs. Lawyers know what they need to do to lose weight. They don'twant to be told what to do. Coaching ensures that what needs to get done,does get done. It is very powerful, and most importantly, it works likeclockwork," added Leventhal.

Leventhal Weight Loss Incorporated coaches attorneys nationwide over thetelephone, and in person in Washington, D.C., Philadelphia, PA, andWilmington, DE. Its clients have come from some of the leading law firms inthe United States including Reed Smith LLP; Dewey & LeBoeuf LLP; Ballard SpahrAndrews & Ingersoll, LLP; Troutman Sanders LLP; and Kirkland & Ellis LLP.

For more information visit or contact MarkLeventhal, Esq., at 202-550-8638 and at

SOURCE Leventhal Weight Loss Incorporated


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Helix BioPharma reports Q2 2008 highlights, financ...
RxElite Filling Critical Requirement for Strategic...